Henrik Everberg
Chief Operating Officer at Pixelgen Technologies AB
Profile
Henrik Everberg is currently the Chief Operating Officer at Pixelgen Technologies AB since 2023.
Prior to this, he worked at Atlas Antibodies AB from 2011 to 2020 as the Head of Production & Logistics from 2015 to 2020.
Dr. Everberg obtained a doctorate degree from the University of Lund.
Henrik Everberg active positions
Companies | Position | Start |
---|---|---|
Pixelgen Technologies AB
Pixelgen Technologies AB BiotechnologyHealth Technology Pixelgen Technologies AB is a company that was founded in 2020 by a team of experienced innovators and entrepreneurs. The company is based in Solna, Sweden. Pixelgen has developed a DNA-based visualization technology called molecular pixelation, which analyzes cell surface proteins to gain insights into cellular activity. The Swedish company aims to deepen the understanding of biology for a healthier world with their technology. Pixelgen's products are covered by one or more claims of patents or pending patent applications. The company was founded by Johan Erik Simon Fredriksson, Alvaro Martinez Barrio, Filip Karlsson, and Fredrik Dahl, with Johan Erik Simon Fredriksson serving as the CEO since 2020. | Chief Operating Officer | 2023-09-11 |
Former positions of Henrik Everberg
Companies | Position | End |
---|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Chief Operating Officer | - |
Training of Henrik Everberg
University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB BiotechnologyHealth Technology Pixelgen Technologies AB is a company that was founded in 2020 by a team of experienced innovators and entrepreneurs. The company is based in Solna, Sweden. Pixelgen has developed a DNA-based visualization technology called molecular pixelation, which analyzes cell surface proteins to gain insights into cellular activity. The Swedish company aims to deepen the understanding of biology for a healthier world with their technology. Pixelgen's products are covered by one or more claims of patents or pending patent applications. The company was founded by Johan Erik Simon Fredriksson, Alvaro Martinez Barrio, Filip Karlsson, and Fredrik Dahl, with Johan Erik Simon Fredriksson serving as the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Henrik Everberg